¶Switching period refers to the patients started with teriflunomide and not applicable to the patients with ofatumumab in core period; For Newly switched group, data from the first dose of TER till last dose of OMB plus 100 days/analysis cutoff date have been used.
Long-term Effect of Ofatumumab on Serum Immunoglobulin Levels in Patients With Relapsing Multiple Sclerosis Wiendl H, et al. Poster Presentation at ECTRIMS 2023. |
|---|
| Mean serum IgG levels remained stable and above the LLN (5.65 g/L) throughout the entire treatment period in both groups and in the majority of the patients (98.5%). Mean serum levels of IgM decreased in both groups, but in the majority of patients (76.9%), IgM levels remained above the LLN (0.40 g/L) |
Ig, Immunoglobulin
